Pneumococcal 20-valent Conjugate Vaccine

CHEBI:CHEBI_755597

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, SUSPENSION
product_type
VACCINE
marketing_category
BLA
pharm_class
Conjugate [CS]
marketing_start_date
20210810
package_marketing_start_date
20210810
active_ingredient_name
STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN
active_ingredient_strength
4.4 ug/.5mL
generic_name
Pneumococcal 20-valent Conjugate Vaccine
brand_name
Prevnar 20
brand_name_base
Prevnar 20
product_ndc
0005-2000
application_number
BLA125731
labeler_name
Wyeth Pharmaceutical Division of Wyeth Holdings LLC
spl_id
1781fc7a-f986-4d6b-938f-0e0bcc0840bd
package_ndc
0005-2000-10
package_description
10 SYRINGE in 1 CARTON (0005-2000-10) / .5 mL in 1 SYRINGE (0005-2000-01)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class